Acute Chest pain
Conditions
Interventions
treatment group:Hydromorphone 1mg was given intravenously and conventional treatment was performed at the same time
Sponsors
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: (1) Age of 18-64 years old; (2) no gender limitation; (3) for patients with acute chest pain, the time from pain onset to visit was =24; (4) severe pain requiring opioid control as judged by the emergency department physician; (5) Informed consent was obtained from patients or their families.
Exclusion criteria
Exclusion criteria: (1) known allergy to hydromorphone or morphine; (2) Systolic blood pressure < 100mmHg, oxygen saturation < 95%, pulse < 60 beats/min;Use of acetaminophen or nonsteroidal anti-inflammatory drugs within the past 8 hours; (4) presence of chronic pain, defined as pain lasting more than 12 weeks; (5) delirium, alcohol withdrawal symptoms or other drug poisoning; (6) pregnant or lactating women; (7) patients with mental and neurological diseases, cognitive and consciousness disorders and unable to express correctly; (8) participating in any other research simultaneously; (9) presence of factors that increase the risk associated with study participation (life-threatening chest requiring rapid diagnostic or therapeutic intervention)Pain patients (resuscitated, excluding chest pain due to myocardial infarction) were judged by the investigator to be ineligible Select the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of pain reduction after 30 minutes of medication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of analgesia;Total dose of remedial medication; | — |
Countries
China
Contacts
Public ContactJun Wang
Nanjing Drum Tower Hospital
Outcome results
None listed